173 related articles for article (PubMed ID: 30589649)
21. Aggressive natural killer (NK)-cell leukaemia and extranodal NK/T-cell lymphoma are two distinct diseases that differ in their clinical presentation and cytogenetic findings.
Yang CF; Hsu CY; Ho DM
Histopathology; 2018 May; 72(6):955-964. PubMed ID: 29314186
[TBL] [Abstract][Full Text] [Related]
22. Small-cell predominant extranodal NK/T cell lymphoma, nasal type: clinicopathological analysis of a series of cases diagnosed in a Western population.
McKelvie PA; Climent F; Krings G; Hasserjian RP; Abramson JS; Pilch BZ; Harris NL; Ferry JA; Zukerberg LR; Sohani AR
Histopathology; 2016 Oct; 69(4):667-79. PubMed ID: 27144366
[TBL] [Abstract][Full Text] [Related]
23. Clinical presentation, treatment, and outcomes of patients with central nervous system involvement in extranodal natural killer/T-cell lymphoma.
Nevel KS; Pentsova E; Daras M
Leuk Lymphoma; 2019 Jul; 60(7):1677-1684. PubMed ID: 30648449
[TBL] [Abstract][Full Text] [Related]
24. Treatment of extranodal NK/T-cell lymphoma: From past to future.
Yan Z; Yao S; Wang Z; Zhou W; Yao Z; Liu Y
Front Immunol; 2023; 14():1088685. PubMed ID: 36825002
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic and molecular features in cutaneous extranodal natural killer-/T-cell lymphoma, nasal type, with aggressive and indolent course.
Fried I; Artl M; Cota C; Müller H; Bartolo E; Boi S; Chiarelli C; Vale E; Schmuth M; Wiesner T; Speicher MR; Cerroni L
J Am Acad Dermatol; 2014 Apr; 70(4):716-723. PubMed ID: 24433873
[TBL] [Abstract][Full Text] [Related]
26. Primary Intestinal Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type: A Comprehensive Clinicopathological Analysis of 55 Cases.
Yu BH; Shui RH; Sheng WQ; Wang CF; Lu HF; Zhou XY; Zhu XZ; Li XQ
PLoS One; 2016; 11(8):e0161831. PubMed ID: 27564014
[TBL] [Abstract][Full Text] [Related]
27. Extranodal NK/T-Cell Lymphoma, Nasal Type in Guatemala: An 86-Case Series Emphasizing Clinical Presentation and Microscopic Characteristics.
Sánchez-Romero C; Paes de Almeida O; Rendón Henao J; Carlos R
Head Neck Pathol; 2019 Dec; 13(4):624-634. PubMed ID: 30900209
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic and Immunophenotypic Features of Primary Intestinal Extranodal NK/T-Cell Lymphoma, Nasal Type.
Fang JC; Xia ZX; Wang CN; Li Z
Int J Surg Pathol; 2015 Dec; 23(8):609-16. PubMed ID: 26183848
[TBL] [Abstract][Full Text] [Related]
29. [Expression of MicroRNA-26a and Its Target Gene CDK6 in Extra-nodal NK/T-Cell Lymphoma].
Huang JX; Wu YA; He YH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Aug; 23(4):1021-5. PubMed ID: 26314438
[TBL] [Abstract][Full Text] [Related]
30. Intestinal T-cell and NK/T-cell lymphomas: A clinicopathological study of 27 Chinese patients.
Tang XF; Yang L; Duan S; Guo H; Guo QN
Ann Diagn Pathol; 2018 Dec; 37():107-117. PubMed ID: 30317149
[TBL] [Abstract][Full Text] [Related]
31. Primary central nervous system extranodal nasal-type natural killer/T-cell lymphoma with CD20 expression.
Li D; Fu F; Lian L
Neuropathology; 2018 Apr; 38(2):198-204. PubMed ID: 29063643
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological features and EBV infection status of lymphoma in children and adolescents in South China: a retrospective study of 662 cases.
Qin C; Huang Y; Feng Y; Li M; Guo N; Rao H
Diagn Pathol; 2018 Feb; 13(1):17. PubMed ID: 29482573
[TBL] [Abstract][Full Text] [Related]
33. Serum EBV EA-IgA and VCA-IgA antibodies can be used for risk group stratification and prognostic prediction in extranodal NK/T cell lymphoma: 24-year experience at a single institution.
Huang Y; Rao H; Yan S; Wang F; Wu Q; Feng Y; Zhang Y
Ann Hematol; 2017 Aug; 96(8):1331-1342. PubMed ID: 28550598
[TBL] [Abstract][Full Text] [Related]
34. [Clinicopathologic features of intestinal natural killer/T-cell lymphoma].
Zhou J; Yu B; He Y; Wu B; Zhang XH; Zhou XJ; Shi QL
Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):243-7. PubMed ID: 23928531
[TBL] [Abstract][Full Text] [Related]
35. [Clinicopathologic study of 963 cases of mature T-cell and natural killer/T-cell lymphoma with respect to 2008 WHO classification of lymphoid neoplasms].
Liang Q; Ye ZY; Su ZL; Lin HL; Shao CK; Lin SX; Rao HL; Mei KY; Zhao T; Liu YH; Luo DL; Zhu MG; Chen SH; Lin TY
Zhonghua Bing Li Xue Za Zhi; 2010 May; 39(5):291-5. PubMed ID: 20654150
[TBL] [Abstract][Full Text] [Related]
36. [Expression of mTOR and 4E-BP1 in extranodal Nasal-type NK/T-cell Lymphoma and implication for prognosis].
Zhang Q; Liu G; Hang W
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2019 Feb; 33(2):123-127. PubMed ID: 30808136
[No Abstract] [Full Text] [Related]
37. A phase II prospective study of the "Sandwich" protocol, L-asparaginase, cisplatin, dexamethasone and etoposide chemotherapy combined with concurrent radiation and cisplatin, in newly diagnosed, I/II stage, nasal type, extranodal natural killer/T-cell lymphoma.
Jiang M; Zhang L; Xie L; Zhang H; Jiang Y; Liu WP; Zhang WY; Tian R; Deng YT; Zhao S; Zou LQ
Oncotarget; 2017 Jul; 8(30):50155-50163. PubMed ID: 28404973
[TBL] [Abstract][Full Text] [Related]
38. [Expression of PDGFRA and CMYC in extranodal NK/T-cell lymphoma and their prognostic implications].
Chen YP; Zhu WF; Lin JY; He TM; Ma HM; Lu JP; Ye XA; Xu CW; Chen G
Zhonghua Bing Li Xue Za Zhi; 2016 Dec; 45(12):825-830. PubMed ID: 28056296
[No Abstract] [Full Text] [Related]
39. Serum B-cell activating factor predicts prognosis in nasal type, extranodal NK/T cell lymphoma.
Zhang L; Li N; Yang L; Zhang J; Weng HW; Zou LQ
Cytokine; 2016 Dec; 88():196-198. PubMed ID: 27668971
[TBL] [Abstract][Full Text] [Related]
40. Laryngeal Extranodal Nasal-type Natural Killer/T-cell Lymphoma: A Clinicopathologic Study of 31 Cases in China.
Xiang CX; Chen ZH; Zhao S; Gao LM; Tao Q; Zuo Z; Liu XY; Liu WP
Am J Surg Pathol; 2019 Jul; 43(7):995-1004. PubMed ID: 31045893
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
